Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
KRAS G12V inhibitor
DRUG CLASS:
KRAS G12V inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
AFNT-211 (1)
YL-17231 (1)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
YK0901 (0)
mutant KRAS G12V-specific TCR transduced autologous T cell therapy (0)
AFNT-211 (1)
YL-17231 (1)
KRAS Mutated Antigen-specific TCR-T Cell Therapy (0)
YK0901 (0)
mutant KRAS G12V-specific TCR transduced autologous T cell therapy (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12V
Solid Tumor
KRAS G12V
Solid Tumor
AFNT-211
Sensitive: C2 – Inclusion Criteria
AFNT-211
Sensitive
:
C2
AFNT-211
Sensitive: C2 – Inclusion Criteria
AFNT-211
Sensitive
:
C2
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
YL-17231
Sensitive: D – Preclinical
YL-17231
Sensitive
:
D
YL-17231
Sensitive: D – Preclinical
YL-17231
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login